Status:

COMPLETED

Efficacy Study of Tissucol/Tisseel Fibrin Sealant to Treat Inguinal Hernia

Lead Sponsor:

University of Milan

Collaborating Sponsors:

Baxter Healthcare Corporation

Pr Giampiero CAMPANELLI

Conditions:

Inguinal Hernia

Eligibility:

MALE

18-80 years

Phase:

PHASE4

Brief Summary

The purpose of the study is to evaluate mid and long term postoperative pain and further disabling complications in open inguinal hernia repair by Lichtenstein technique after mesh fixation with fibri...

Detailed Description

Subjects in the FS group will be operated by Lichtenstein technique, with mesh fixation by fibrin sealant. Subjects in control group will be operated with conventional Lichtenstein technique (mesh fix...

Eligibility Criteria

Inclusion

  • Signed informed consent obtained from the subject prior to participation in the study
  • Active males over the age of 18 years and below 80 years
  • Experiencing an uncomplicated unilateral primary inguinal hernia or experiencing an uncomplicated bilateral hernia provided that only one hernia is operated during the 12 months of study follow-up
  • Subjects eligible for elective inguinal hernia repair using Lichtenstein technique.

Exclusion

  • Recurrent, scrotal, incarcerated or femoral hernias
  • Hernia types L3 and M3 according the EHS classification
  • BMI equal or more than 35
  • Concomitant abdominal surgery
  • Ongoing long term analgesic or steroid treatment
  • Patients under Clopidogrel or Warfarin (can be switched to LMW sub-cutaneous heparin)
  • Known abuse of alcohol or drugs
  • Liver cirrhosis (Child C)
  • Previous treatment or Hypersensitivity to bovine aprotinin
  • Known immunodeficiency
  • Severely compromised physical or psychological health, that in the investigator's opinion will affect patient compliance
  • Concurrently participating in another clinical trial and having received another investigational drug or device within the last 30 days

Key Trial Info

Start Date :

February 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2008

Estimated Enrollment :

325 Patients enrolled

Trial Details

Trial ID

NCT00306839

Start Date

February 1 2006

End Date

May 1 2008

Last Update

February 13 2009

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Gasthuisberg University Hospitals KUL

Leuven, Belgium, 3000

2

Copenhagen university hospital, Gentofte

Hellerup, Denmark, 2900

3

Hôpital Jean Verdier

Bondy, France, 93143

4

St. Hildegardis-Krankenhaus

Mainz, Germany, 55131